Your browser doesn't support javascript.
loading
Modulation of hippocampal activity in schizophrenia with levetiracetam: a randomized, double-blind, cross-over, placebo-controlled trial.
Roeske, Maxwell J; McHugo, Maureen; Rogers, Baxter; Armstrong, Kristan; Avery, Suzanne; Donahue, Manus; Heckers, Stephan.
Afiliação
  • Roeske MJ; Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA. maxwell.j.roeske.2@vumc.org.
  • McHugo M; Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Rogers B; Vanderbilt University Institute of Imaging Sciences, Nashville, TN, USA.
  • Armstrong K; Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Avery S; Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Donahue M; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Heckers S; Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
Neuropsychopharmacology ; 49(4): 681-689, 2024 Mar.
Article em En | MEDLINE | ID: mdl-37833590
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piracetam / Esquizofrenia Limite: Humans Idioma: En Revista: Neuropsychopharmacology Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piracetam / Esquizofrenia Limite: Humans Idioma: En Revista: Neuropsychopharmacology Ano de publicação: 2024 Tipo de documento: Article